BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37633095)

  • 1. Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis.
    van Walle L; Verhoeven D; Marotti L; Ponti A; Tomatis M; Rubio IT;
    Eur J Cancer; 2023 Oct; 192():113244. PubMed ID: 37633095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.
    van Dam PA; Tomatis M; Marotti L; Heil J; Mansel RE; Rosselli Del Turco M; van Dam PJ; Casella D; Bassani LG; Danei M; Denk A; Egle D; Emons G; Friedrichs K; Harbeck N; Kiechle M; Kimmig R; Koehler U; Kuemmel S; Maass N; Mayr C; Prové A; Rageth C; Regolo L; Lorenz-Salehi F; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Audisio R; Ponti A;
    Eur J Cancer; 2017 Nov; 85():15-22. PubMed ID: 28881247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres.
    van Dam P; Tomatis M; Ponti A; Marotti L; Aristei C; Biganzoli L; Cardoso MJ; Cheung KL; Curigliano G; De Vries J; Santini D; Sardanelli F; Rubio IT;
    Eur J Cancer; 2022 Dec; 177():72-79. PubMed ID: 36332437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of EUSOMA certification on quality of breast cancer care.
    van Dam PA; Tomatis M; Marotti L; Heil J; Wilson R; Rosselli Del Turco M; Mayr C; Costa A; Danei M; Denk A; Emons G; Friedrichs K; Harbeck N; Kiechle M; Koheler U; Kuemmel S; Maass N; Marth C; Prové A; Kimmig R; Rageth C; Regolo L; Salehi L; Sarlos D; Singer C; Sohn C; Staelens G; Tinterri C; Ponti A; ;
    Eur J Surg Oncol; 2015 Oct; 41(10):1423-9. PubMed ID: 26278019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The process of EUSOMA certification improves the quality of breast cancer care: the experience of an Italian EUSOMA certificated Breast Unit (BU) according to the results of a cross-sectional study.
    Gazzani D; Dai Prè A; Sandrini R; Governa M; Favaro A; Zogno A; Remo A; Greco F; Molinari E; Aguzzi G; Signorelli D; Caprara D; Costa L; Zanella C; Signorini M; Mercanti A; Giuliani J; Zambelli L; Majori S; Moretti F; Bonetti A
    Recenti Prog Med; 2021 Jun; 112(6):458-464. PubMed ID: 34128938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.
    Cowppli-Bony A; Trétarre B; Marrer E; Defossez G; Daubisse-Marliac L; Coureau G; Minicozzi P; Woronoff AS; Delafosse P; Molinié F;
    PLoS One; 2019; 14(10):e0224275. PubMed ID: 31644603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Naume B; Nygård JF
    Int J Med Inform; 2019 May; 125():102-109. PubMed ID: 30914174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database.
    Garcia-Etienne CA; Tomatis M; Heil J; Friedrichs K; Kreienberg R; Denk A; Kiechle M; Lorenz-Salehi F; Kimmig R; Emons G; Danaei M; Heyl V; Heindrichs U; Rageth CJ; Janni W; Marotti L; del Turco MR; Ponti A;
    Eur J Cancer; 2012 Sep; 48(13):1947-56. PubMed ID: 22483323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: a European Society of Breast Cancer Specialists database analysis.
    Kiderlen M; Ponti A; Tomatis M; Boelens PG; Bastiaannet E; Wilson R; van de Velde CJ; Audisio RA;
    Eur J Cancer; 2015 Jul; 51(10):1221-30. PubMed ID: 25892645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?
    Lin H; Zheng H; Ge C; Wang Q; Tang W; Zhang X; Zhou S; Jin X; Xu X; Du J; Fu J
    Clin Breast Cancer; 2020 Dec; 20(6):503-510. PubMed ID: 32653474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality.
    Battisti NML; Hatton MQ; Reed MWR; Herbert E; Morgan JL; Bradburn M; Simcock R; Walters SJ; Collins KA; Ward SE; Holmes GR; Burton M; Lifford KJ; Edwards A; Robinson TG; Martin C; Chater T; Pemberton KJ; Brennan A; Leung Cheung K; Todd A; Audisio RA; Wright J; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeshwar R; Gosney MA; Thompson AM; Wyld L; Ring A;
    Radiother Oncol; 2021 Aug; 161():166-176. PubMed ID: 34146616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators.
    Héquet D; Huchon C; Baffert S; Alran S; Reyal F; Nguyen T; Combes A; Trichot C; Alves K; Berseneff H; Rouzier R
    Br J Cancer; 2017 May; 116(11):1394-1401. PubMed ID: 28441385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of early breast cancer during the COVID-19 pandemic in Brazil.
    Cavalcante FP; Novita GG; Millen EC; Zerwes FP; de Oliveira VM; Sousa ALL; Freitas Junior R
    Breast Cancer Res Treat; 2020 Nov; 184(2):637-647. PubMed ID: 32803637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
    Velikova G; Williams LJ; Willis S; Dixon JM; Loncaster J; Hatton M; Clarke J; Kunkler IH; Russell NS;
    Lancet Oncol; 2018 Nov; 19(11):1516-1529. PubMed ID: 30337220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).
    Biganzoli L; Wildiers H; Oakman C; Marotti L; Loibl S; Kunkler I; Reed M; Ciatto S; Voogd AC; Brain E; Cutuli B; Terret C; Gosney M; Aapro M; Audisio R
    Lancet Oncol; 2012 Apr; 13(4):e148-60. PubMed ID: 22469125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
    Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUSOMA quality indicators for non-metastatic breast cancer: An update.
    Rubio IT; Marotti L; Biganzoli L; Aristei C; Athanasiou A; Campbell C; Cardoso F; Cardoso MJ; Coles CE; Eicher M; Harbeck N; Karakatsanis A; Offersen BV; Pijnappel R; Ponti A; Regitnig P; Santini D; Sardanelli F; Spanic T; Varga Z; Vrancken Peeters MJTFD; Wengström Y; Wyld L; Curigliano G
    Eur J Cancer; 2024 Feb; 198():113500. PubMed ID: 38199146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 360 Health Analysis (H360)-A Comparison of Key Performance Indicators in Breast Cancer Management across Health Institution Settings in Portugal.
    Rego IB; Coelho S; Semedo PM; Cavaco-Silva J; Teixeira L; Sousa S; Reis J; Dinis R; Schmitt F; Afonso N; Fougo JL; Pavão F; Baptista Leite R; Costa L
    Curr Oncol; 2023 Jun; 30(7):6041-6065. PubMed ID: 37504311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.
    Blackwell K; Gligorov J; Jacobs I; Twelves C
    Clin Breast Cancer; 2018 Apr; 18(2):95-113. PubMed ID: 29525430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.